Using histamine (H1) antagonists, in particular atypical antipsychotics, to treat anemia of chronic disease via interleukin-6 suppression

Medical Hypotheses

Volumn 65, Issue 1, 2005, Pages 65-67

  Altschuler, Eric Lewin ^a   Kast, Richard E ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 6; IRON; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE;

ANEMIA; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG POTENCY; HUMAN; IRON INTAKE; IRON THERAPY; PATHOGENESIS; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; TREATMENT OUTCOME;

ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; DIBENZOTHIAZEPINES; DOWN-REGULATION; GENE EXPRESSION REGULATION; HISTAMINE ANTAGONISTS; HUMANS; INTERLEUKIN-6; IRON; MODELS, BIOLOGICAL; RECEPTORS, HISTAMINE H1; UP-REGULATION;

EID: 18944387640     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.01.036     Document Type: Article

References (5)

1. J.M. Cash, and D.A. Sears The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients Am J Med 87 1989 638 644
2. R.T. Means Jr. Advances in the anemia of chronic disease Int J Hematol 70 1999 7 12
3. A. Pietrangelo, and C. Trautwein Mechanisms of disease: the role of hepcidin in iron hemostatis implications for hemachromatosis and other disorders Nat Clin Pract Gastroenterol Hepatol 1 2004 39 45
4. 1 receptors J Immunol 166 2001 4083 4091
5. E. Richelson, and T. Souder Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds Life Sci 68 2000 29 39